Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 931

Similar articles for PubMed (Select 16648862)

2.

Analysis of transcription factor OCT.1, OCT.2 and BOB.1 expression using tissue arrays in classical Hodgkin's lymphoma.

García-Cosío M, Santón A, Martín P, Camarasa N, Montalbán C, García JF, Bellas C.

Mod Pathol. 2004 Dec;17(12):1531-8.

3.

B-cell transcription factors Pax-5, Oct-2, BOB.1, Bcl-6, and MUM1 are useful markers for the diagnosis of nodular lymphocyte predominant Hodgkin lymphoma.

Herbeck R, Teodorescu Brînzeu D, Giubelan M, Lazăr E, Dema A, Ioniţă H.

Rom J Morphol Embryol. 2011;52(1):69-74.

4.

Lymphocyte-rich classical Hodgkin's lymphoma: distinctive tumor and microenvironment markers.

Nam-Cha SH, Montes-Moreno S, Salcedo MT, Sanjuan J, Garcia JF, Piris MA.

Mod Pathol. 2009 Aug;22(8):1006-15. doi: 10.1038/modpathol.2009.54. Epub 2009 May 22.

5.

Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and in subsets of B-cell lymphomas.

Krenacs L, Himmelmann AW, Quintanilla-Martinez L, Fest T, Riva A, Wellmann A, Bagdi E, Kehrl JH, Jaffe ES, Raffeld M.

Blood. 1998 Aug 15;92(4):1308-16.

6.

Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease.

Marafioti T, Mancini C, Ascani S, Sabattini E, Zinzani PL, Pozzobon M, Pulford K, Falini B, Jaffe ES, Müller-Hermelink HK, Mason DY, Pileri SA.

Haematologica. 2004 Aug;89(8):957-64.

7.

Analysis of octamer-binding transcription factors Oct2 and Oct1 and their coactivator BOB.1/OBF.1 in lymphomas.

Sáez AI, Artiga MJ, Sánchez-Beato M, Sánchez-Verde L, García JF, Camacho FI, Franco R, Piris MA.

Mod Pathol. 2002 Mar;15(3):211-20.

9.

Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines.

Arguello M, Sgarbanti M, Hernandez E, Mamane Y, Sharma S, Servant M, Lin R, Hiscott J.

Oncogene. 2003 Feb 20;22(7):964-73.

PMID:
12592383
10.
11.

Clusterin expression in malignant lymphomas: a survey of 266 cases.

Saffer H, Wahed A, Rassidakis GZ, Medeiros LJ.

Mod Pathol. 2002 Nov;15(11):1221-6.

12.

T-bet, a T cell-associated transcription factor, is expressed in Hodgkin's lymphoma.

Dorfman DM, Hwang ES, Shahsafaei A, Glimcher LH.

Hum Pathol. 2005 Jan;36(1):10-5.

PMID:
15712176
13.

Oct-2 and Bob-1 deficiency in Hodgkin and Reed Sternberg cells.

Re D, Müschen M, Ahmadi T, Wickenhauser C, Staratschek-Jox A, Holtick U, Diehl V, Wolf J.

Cancer Res. 2001 Mar 1;61(5):2080-4.

14.

Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.

Nguyen PL, Harris NL, Ritz J, Robertson MJ.

Am J Pathol. 1996 Mar;148(3):847-53. Erratum in: Am J Pathol 1996 Jul;149(1):346.

16.

Use of an expanded immunohistochemical panel to distinguish cutaneous Hodgkin lymphoma from histopathologic imitators.

Cho RJ, McCalmont TH, Ai WZ, Fox LP, Treseler P, Pincus LB.

J Cutan Pathol. 2012 Jun;39(6):651-8. doi: 10.1111/j.1600-0560.2012.01872.x. Epub 2012 Feb 11.

PMID:
22324490
17.
18.

T-cell/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: differential diagnosis from Hodgkin's lymphoma.

Fraga M, Sánchez-Verde L, Forteza J, García-Rivero A, Piris MA.

Histopathology. 2002 Sep;41(3):216-29.

PMID:
12207783
20.

Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.

Massarelli G, Onida GA, Piras MA, Marras V, Mura A, Tanda F.

Anticancer Res. 1999 Sep-Oct;19(5B):3933-8.

PMID:
10628334
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk